Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 7, 2013, Pages

  Churchill, David ^a   Duley, Lelia ^b   Thornton, Jim G ^c   Jones, Leanne ^d  

^a NEW CROSS HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CESAREAN SECTION; COMPARATIVE EFFECTIVENESS; DISEASE SEVERITY; EXPECTANT CARE; GESTATIONAL AGE; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; HYALINE MEMBRANE DISEASE; INTERVENTIONIST CARE; MATERNAL CARE; NEWBORN DEATH; NEWBORN INTENSIVE CARE; OBSTETRIC DELIVERY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; SMALL FOR DATE INFANT; STILLBIRTH; SYSTEMATIC REVIEW; TREATMENT OUTCOME; DELIVERY; FEMALE; META ANALYSIS; METHODOLOGY; NECROTIZING ENTEROCOLITIS; NEWBORN; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS; WATCHFUL WAITING; ENTEROCOLITIS, NECROTIZING; PRE-ECLAMPSIA; STATISTICS AND NUMERICAL DATA;

CESAREAN SECTION; DELIVERY, OBSTETRIC; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; HYALINE MEMBRANE DISEASE; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WATCHFUL WAITING;

EID: 84891651017     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003106.pub2     Document Type: Review

References (36)

1. GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and bayesian interpretation. BJOG: an international journal of obstetrics and gynaecology 2003;110:27-32.
2. Hornbuckle J, Thornton JG, Vail A, GRIT SG. The Growth Restriction Intervention Trial (GRIT): interim progress report. Women's Health - into the new millennium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3-6; Cape Town South Africa. RCOG, 1999:76.
3. Schneider KTM, Brocker J, Thornton J. A randomised intervention of timed delivery for the compromised preterm fetus [abstract] [Randomisierte Intervention zur Optimierung des Entbindungszeitpunktes bei kompromittierten IUGR-Feten (Euro-GRIT)]. Geburtshilfe und Frauenheilkunde 2000;60 Suppl 1:S72.
4. Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M, GRIT study group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004;364:513-20.
5. Walker DM, Marlow N, Upstone L, Gross H, Hornbuckle J, Vail A, et al. The Growth Restriction Intervention Trial: long-term outcomes in a randomized trial of timing of delivery in fetal growth restriction. American Journal of Obstetrics and Gynecology 2011;204(1):34.e1-9.
6. Mesbah EMM. Severe preterm preeclampsia: aggressive or expectant management?. Medical Journal of Cairo University 2003;71(1):175-82.
7. Odendaal HJ, Pattinson RC. Active or conservative treatment of severe preeclampsia - a randomized control trial. Proceedings of 37th Annual Meeting of the Society for Gynecologic Investigation; 1990 March 21-24; St Louis, USA. 1990:359.
8. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstetrics & Gynecology 1990;76:1070-5.
9. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. American Journal of Obstetrics and Gynecology 1994;171:818-22.
10. Gruppo di Studio Ipertensione in Gravidanza. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. British Journal of Obstetrics and Gynaecology 1998;105:718-22.
11. Langenveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): A multicentre, open-label randomised controlled trial. BMC Pregnancy and Childbirth 2011;11:50.
12. Duvekot JJ, Steegers EAP, Hop WCJ, Franx A, van der Post JAM, van Wassenaer A, et al. TOTEM study (temporise or terminate pregnancy in women with severe preeclampsia at 28-34 weeks): a study protocol. Pregnancy Hypertension 2011;1 Suppl 1:295.
13. Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin J-M. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy. Hypertension in Pregnancy 2001;20:ix-xiv.
14. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database of Systematic Reviews 1996, Issue 1. [DOI: 10.1002/14651858.CD000065.pub2]
15. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders in pregnancy. American Journal of Obstetrics and Gynecology 1988;158:892-8.
16. Derham RJ, Hawkins DF, deVries LS, Aber VR, Elder MG. Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks: stepwise logistic regression analysis of prognostic factors. British Journal of Obstetrics and Gynaecology 1989;96:1173-81.
17. Duley L, Henderson-Smart D. Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy. Cochrane Database of Systematic Reviews 1999, Issue 3. [DOI: 10.1002/14651858.CD001687]
18. Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of pre-eclampsia. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD001805]
19. Duley L, Henderson-Smart D, Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD005548]
20. Duley L, Henderson-Smart DJ. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001449.pub2]
21. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD004659.pub2]
22. Duley L, Henderson-Smart DJ, Walker GJA. Interventions for treating pre-eclampsia and its consequences: generic protocol. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD007756]
23. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD000025.pub2]
24. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
25. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
26. Hofmeyr GJ, Lawrie TA, Atallah ÁN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews 2010, Issue 8. [DOI: 10.1002/14651858.CD001059.pub3]
27. Magee LA, Yong PJ, Espinosa V, Cote AM, Chen I, von Dadelszen P. Expectant management of severe pre-eclampsia remote from term: a structured systematic review. Hypertension in Pregnancy 2009;28(3):312-47.
28. Makrides M, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000937]
29. Morris RK, Riley RD, Doug M, Deeks JJ, Kilby MD. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. BMJ (Clinical research ed.) 2012;345:e4342. [PUBMED: 22777026]
30. Royal College of Obstetricians and Gynaecologists. Pre-eclampsia - study group consensus statement. http://www.rcog.org.uk/print/womens-health/clinical-guidance/pre-eclampsia-study-group-consensus-statement 2003.
31. The Cochrane Collaboration. Review Manager (RevMan). 4.1 for Windows. Oxford, England: The Cochrane Collaboration, 2000.
32. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
33. Sibai BM, Spinnato JA, Watson DL, Hill GA, Anderson GD. Pregnancy outcome in 303 cases with severe preeclampsia. Obstetrics & Gynecology 1984;64:319-25.
34. von Dadelszen P, Payne B, Li J, Ansermino MJ, Broughton FP, Cote A, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011;377(9761):219-27.
35. Churchill D, Duley L 10.1002/14651858.CD003106. Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003106]
36. Duley L. Aggressive vs expectant management of pre-eclampsia. In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Database of Systematic Reviews [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.